A pivotal study of Donepezil transdermal patch in healthy volunteers

Trial Profile

A pivotal study of Donepezil transdermal patch in healthy volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Donepezil (Primary) ; Donepezil
  • Indications Alzheimer's disease
  • Focus Pharmacokinetics; Registrational
  • Sponsors Corium International
  • Most Recent Events

    • 03 Aug 2017 According to a Corium International media release, topline results are expected in the first calendar quarter of 2018, and the company is targeting submission of a Section 505(b)(2) New Drug Application (NDA) in the second half of calendar 2018
    • 03 Aug 2017 According to a Corium International media release, dosing in this trial is expected to begin before the end of September 2017.
    • 03 Aug 2017 According to a Corium International media release, status changed from planning to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top